Skip to main content

Anterior Myocardial Infarction

0
Pipeline Programs
2
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Sungen Biomedical
Sungen BiomedicalChina - Beijing
3 programs
SGC001PHASE_11 trial
SGC001PHASE_11 trial
SGC001PHASE_21 trial
Active Trials
NCT07079618Completed49Est. Jul 2025
NCT07091929Completed38Est. Jul 2025
NCT07306182Not Yet Recruiting210Est. Jun 2027
Miracor Medical
Miracor MedicalBelgium - Awans
1 program
PiCSO Impulse SystemN/A1 trial
Active Trials
NCT05644925Withdrawn0Est. Jun 2024

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
2027
Sungen BiomedicalSGC001
Sungen BiomedicalSGC001
Sungen BiomedicalSGC001
Miracor MedicalPiCSO Impulse System

Clinical Trials (4)

Total enrollment: 297 patients across 4 trials

NCT07306182Sungen BiomedicalSGC001

A Research Study to Evaluate the Efficacy and Safety of SGC001 in Patients With Anterior Wall ST-Segment Elevation Myocardial Infarction

Start: Feb 2026Est. completion: Jun 2027210 patients
Phase 2Not Yet Recruiting
NCT07091929Sungen BiomedicalSGC001

A Research Study to Evaluate the Safety and Preliminary Efficacy of SGC001 in Patients With Myocardial Infarction

Start: Jan 2025Est. completion: Jul 202538 patients
Phase 1Completed
NCT07079618Sungen BiomedicalSGC001

A Research Study to Evaluate the Safety and Tolerability of SGC001 in Healthy Subjects

Start: Aug 2024Est. completion: Jul 202549 patients
Phase 1Completed
NCT05644925Miracor MedicalPiCSO Impulse System

Effects of Pressure-controlled Intermittent Coronary Sinus Occlusion (PiCSO) Therapy on miRNAs Expression and Absolute Microvascular Resistance by Continuous Thermodilution in ST-segment Elevation Myocardial Infarction (STEMI) Patients: PiCSO-STEMI TRIAL

Start: Nov 2022Est. completion: Jun 20240
N/AWithdrawn

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.